REQUEST A DEMO
Total
USD $0.00
Search more companies

Srinija Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Srinija Drugs Private Limited Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Srinija Drugs Private Limited is an unlisted company, incorporated on 17/04/2000. It has its registered office in the State of Andhra Pradesh LLP, India. Company's corporate identification number (CIN) is U24233AP2000PTC034263 and registration number is 034263.

Legal Address
P.N.245, Ida,Kondapally Vijayawada
Krishna District; Andhra Pradesh; Postal Code: 521228

Contact Details: Purchase the Srinija Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Srinija Drugs Private Limited report to view the information.
Outstanding Shares:
Purchase the Srinija Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Srinija Drugs Private Limited report to view the information.
Incorporation Date:
April 17, 2000
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Srinija Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
64.47%
Total operating revenue
64.3%
Operating profit (EBIT)
153.85%
EBITDA
70.25%
Net Profit (Loss) for the Period
125.44%
Total assets
7.16%
Total equity
21.05%
Operating Profit Margin (ROS)
2.34%
Net Profit Margin
1.34%
Return on Equity (ROE)
8.05%
Debt to Equity Ratio
-28.17%
Quick Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?